These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 38922155)

  • 1. Embracing the Versatility of Botulinum Neurotoxins in Conventional and New Therapeutic Applications.
    Rasetti-Escargueil C; Palea S
    Toxins (Basel); 2024 Jun; 16(6):. PubMed ID: 38922155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Botulinum Neurotoxins for Enhanced Therapeutic Applications and Vaccine Development.
    Rasetti-Escargueil C; Popoff MR
    Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expanding Therapeutic Utility of Botulinum Neurotoxins.
    Fonfria E; Maignel J; Lezmi S; Martin V; Splevins A; Shubber S; Kalinichev M; Foster K; Picaut P; Krupp J
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
    Chen S
    Toxins (Basel); 2012 Oct; 4(10):913-39. PubMed ID: 23162705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip.
    Tehran DA; Pirazzini M
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and future directions of botulinum neurotoxins for targeting pain processing.
    Pellett S; Yaksh TL; Ramachandran R
    Toxins (Basel); 2015 Nov; 7(11):4519-63. PubMed ID: 26556371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).
    Kane CD; Nuss JE; Bavari S
    Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Opportunities in Human Pluripotent Stem-Cells Based Assays to Explore the Diversity of Botulinum Neurotoxins as Future Therapeutics.
    Duchesne de Lamotte J; Perrier A; Martinat C; Nicoleau C
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
    Pickett A
    BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Structure and Classification of Botulinum Toxins.
    Dong M; Stenmark P
    Handb Exp Pharmacol; 2021; 263():11-33. PubMed ID: 31792680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability of Botulinum Toxins: Challenges and Opportunities for the Future.
    Rasetti-Escargueil C; Lemichez E; Popoff MR
    Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light Chain Diversity among the Botulinum Neurotoxins.
    Gardner AP; Barbieri JT
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30004421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.
    Pirazzini M; Rossetto O; Eleopra R; Montecucco C
    Pharmacol Rev; 2017 Apr; 69(2):200-235. PubMed ID: 28356439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of botulinum neurotoxin therapy].
    Mukai Y; Kaji R
    Brain Nerve; 2011 Jul; 63(7):775-84. PubMed ID: 21747148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA .
    Karalewitz AP; Kroken AR; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
    Biochemistry; 2010 Sep; 49(37):8117-26. PubMed ID: 20731382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum and Tetanus Neurotoxins.
    Dong M; Masuyer G; Stenmark P
    Annu Rev Biochem; 2019 Jun; 88():811-837. PubMed ID: 30388027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal selectivity of botulinum neurotoxins.
    Poulain B; Lemichez E; Popoff MR
    Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering Botulinum Toxins to Improve and Expand Targeting and SNARE Cleavage Activity.
    Fonfria E; Elliott M; Beard M; Chaddock JA; Krupp J
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 29973505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
    Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J
    Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
    Del Sorbo F; Albanese A
    Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.